Association for Accessible Medicines
601 New Jersey Ave NW, Suite 850
Washington, DC 20001
P: 202.249.7100
E: [email protected]
Anand Saxena is the Director of Regulatory Affairs at Cipla Limited. He holds a postgraduate degree in Organic Chemistry and has over 24 years of experience in Regulatory Affairs. His current responsibilities include managing and leading a team in regulatory activities related to pre-IND, pre-ANDA, controlled correspondence, PFC submission, ANDA & NDA submission. He handles deficiency reviews and submissions, provides regulatory support for product launches and post-approval life cycle management. Providing support in terms of regulatory strategies during new product selection for development, due diligence, labeling, product launch, and publishing. His regulatory experience spans various dosage forms, including including complex injectable, topical, ophthalmic, respiratory inhalation, inhalers and nasal sprays etc.